Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Investigational Influenza Vaccine
BIOLOGICAL
4 trials
Sponsors
BioNTech SE
, ModernaTX, Inc.
Conditions
COVID-19
COVID-19 (Coronavirus Disease 2019)
Influenza
Influenza,Human
SARS-CoV-2
Phase 1
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Completed
NCT06683352
BioNTech SE
COVID-19, Influenza,Human
Start: 2024-11-11
End: 2025-07-15
Updated: 2026-08-19
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Completed
NCT06821061
BioNTech SE
COVID-19 (Coronavirus Disease 2019), Influenza
Start: 2025-02-10
End: 2025-12-17
Updated: 2026-01-26
Phase 2
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
Completed
NCT06864143
ModernaTX, Inc.
Influenza, SARS-CoV-2
Start: 2025-03-07
End: 2025-10-13
Updated: 2025-10-20
Phase 3
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
Completed
NCT06178991
BioNTech SE
COVID-19, Influenza
Start: 2023-12-20
End: 2024-11-26
Updated: 2025-12-04
Related Papers
Phase 3 Randomized Study Investigating the Safety, Tolerability, and Immunogenicity of a Combination Modified Messenger RNA Vaccine Against Influenza and COVID-19 in Healthy Adults
Vaccines
2026-08-05